Pharmaceutical residues in the Baltic Sea environment are causing concern even though the full impact for the marine environment is still unknown. Many pharmaceuticals substances cannot be effectively removed by conventional waste water treatment. The flagship on pharmaceuticals in the Baltic Sea environment is designed as an umbrella/platform for the implementation of projects and different types of activities aiming to reduce pharmaceutical in the Baltic environment, as well as to support regional policy development and stakeholder cooperation.
The project aims to:
• Contribute to the identification, development and implementation of (transnational) projects and activities within the area of pharmaceuticals in the environment, as well as foster synergies between them
• Catalyse exchange of information and best practices in the region
• Promote stakeholder cooperation and awareness in the Baltic region
• Support the development of regional policy in the area of pharmaceuticals in the environment
• Implementation of physical measures resulting in reduced emissions of pharmaceuticals to the Baltic environment
• Development of regional policy, e.g. a regional strategy, recommendation or guidelines
• Development of projects and activities tackling the problem through e.g. waste water and sludge management, clean-tech innovation and public procurement
The flagship is targeting both human and veterinary medicines. Activities mainly focus on non-regulatory solutions.
The flagship contributes to the EUSBSR objective "Save the Sea" and its sub-objectives "Clean water" and "Rich and healthy wildlife" by focussing on pharmaceuticals as a group of chemicals that includes emerging pollutants which are assessed to pose a risk aquatic life at individual as well as community level, and potentially to human health.
The project involves partners from Denmark, Estonia, Finland, Germany, Latvia, Lithuania, Poland and Sweden as well as HELCOM.